Green Thumb Industries (Green Thumb Industries) Growth Rank : 0 (As of Jun. 08, 2024)

View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Growth Rank?

Green Thumb Industries has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Green Thumb Industries Growth Rank Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Thumb Industries (Green Thumb Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

R9U2:Germany GTII:Canada

Address

325 West Huron Street, Suite 700, Chicago, IL, USA, 60654

Website

https://www.gtigrows.com

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 87 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM.

Executives

Richard Reisin	director	325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan	director	660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz	officer: GENERAL COUNSEL AND SECRETARY	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman	director	325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler	director	200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter	director	6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu	director	325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner	officer: Chief Accounting Officer	325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk	officer: General Counsel	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler	director, 10 percent owner, officer: Chairman & CEO	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian	officer: President	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley	other: Chief Strategy Officer	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore	director	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654